- Home
- NVG vs NARI Comparison
NVG vs NARI Comparison
Compare NVG & NARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVG
- NARI
- Stock Information
- Founded
- NVG 1999
- NARI 2011
- Country
- NVG United States
- NARI United States
- Employees
- NVG N/A
- NARI N/A
- Industry
- NVG Investment Managers
- NARI Medical/Dental Instruments
- Sector
- NVG Finance
- NARI Health Care
- Exchange
- NVG Nasdaq
- NARI Nasdaq
- Market Cap
- NVG 2.7B
- NARI 3.1B
- IPO Year
- NVG N/A
- NARI 2020
- Fundamental
- Price
- NVG $12.87
- NARI $50.56
- Analyst Decision
- NVG
- NARI Buy
- Analyst Count
- NVG 0
- NARI 10
- Target Price
- NVG N/A
- NARI $59.13
- AVG Volume (30 Days)
- NVG 568.8K
- NARI 941.7K
- Earning Date
- NVG 01-01-0001
- NARI 10-28-2024
- Dividend Yield
- NVG 4.65%
- NARI N/A
- EPS Growth
- NVG N/A
- NARI N/A
- EPS
- NVG N/A
- NARI N/A
- Revenue
- NVG N/A
- NARI $574,498,000.00
- Revenue This Year
- NVG N/A
- NARI $24.59
- Revenue Next Year
- NVG N/A
- NARI $18.28
- P/E Ratio
- NVG N/A
- NARI N/A
- Revenue Growth
- NVG N/A
- NARI 22.41
- 52 Week Low
- NVG $9.68
- NARI $36.73
- 52 Week High
- NVG $12.21
- NARI $67.13
- Technical
- Relative Strength Index (RSI)
- NVG 49.07
- NARI 57.58
- Support Level
- NVG $12.71
- NARI $49.96
- Resistance Level
- NVG $13.08
- NARI $53.67
- Average True Range (ATR)
- NVG 0.15
- NARI 2.37
- MACD
- NVG 0.05
- NARI 0.02
- Stochastic Oscillator
- NVG 68.84
- NARI 56.20
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax. The Fund invests predominantly in investment grade municipal bonds that are exempt from regular federal income taxes.
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.